Thyroid Diseases  >>  Erbitux (cetuximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Erbitux (cetuximab) / Eli Lilly, EMD Serono
NCT01057589 / 2009-011611-21: A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Completed
2
66
Europe
Pemetrexed, Alimta, LY231514, Cetuximab, Cisplatin, Folic Acid, Vitamin B12
Eli Lilly and Company
Head and Neck Neoplasms
02/12
10/12

Download Options